JAZZ
Jazz Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.44 / 10
Netural
Technical rating sits at 5.44/10, neutral. RSI shows overbought momentum (score 7.41) suggesting short‑term strength, whereas MACD signals a death cross (score 3.47) indicating potential downside. Recent five‑day data reveal limited new signals, keeping the trend ambiguous.
Analysis Checks(1/2)
RSI Overbought
Score7.41/10
Win Rate65.00%
Hist. Signals20
Avg Return0.99%
Score7.41/10
Win Rate65.00%
Hist. Signals20
Avg Return0.99%
MACD Death Cross
Score3.47/10
Win Rate50.00%
Hist. Signals6
Avg Return-0.67%
Score3.47/10
Win Rate50.00%
Hist. Signals6
Avg Return-0.67%
RSI Overbought
Score7.41/10
Win Rate65.00%
Hist. Signals20
Avg Return0.99%
Score7.41/10
Win Rate65.00%
Hist. Signals20
Avg Return0.99%
MACD Death Cross
Score3.47/10
Win Rate50.00%
Hist. Signals6
Avg Return-0.67%
Score3.47/10
Win Rate50.00%
Hist. Signals6
Avg Return-0.67%
What is the current technical signals for JAZZ?
- JAZZ presents a Netural setup with a Technical Score of 5.44/10. Key technical indicators highlight an RSI of 63.01 and a MACD of -0.43, with the trend anchored by the 50-Day SMA at 174.96. Traders should monitor key support at 182.10 and resistance at 186.50.
